RxDoctor Payments Data

Mark McBride, MD

Orthopaedic Surgery · San Diego, CANPI 1659381077

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,434,396 of the $2,584,922 with a category attached, or 94.2%. Encore Medical, LP accounts for 99.9% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $619,293, 2.1 times the $300,734 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,584,922in general payments, 2019–2025

Across 229 payments — averaging $11,288 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$2.6M
  • Linvatec Corporation$1K
  • Medtronic$700
  • Zimmer Biomet$144
  • Davol Inc.$116
  • Lima USA, Inc.$100
  • plus $261 from 7 others

What the payments were for

  • Royalty or licence$2,434,39694%
  • Consulting fees$136,9505%
  • Travel & lodging$8,6370%
  • Food & beverage$4,9390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,584,922 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$39,286
Medicare patients
80
Services billed
206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl21$138

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →